The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Likhvantseva V.G.

Tsentral'naia klinicheskaia bol'nitsa RAN, Moskva

Afanasev M.S.

I.M. Sechenov First Moscow State Medical University, Malaya Trubetskaya st., 8/2, Moscow, Russian Federation, 119991

Rudenko E.A.

Institution of Advanced Training, Federal Medical and Biological Agency, 91 Volokolamskoye Shosse, Moscow, Russian Federation, 125371

Karaulov A.V.

GBOU VPO Pervyĭ MGMU im. I.M. Sechenova

Afanas’ev S.S.

FBUN «MNIIEM im. G.N. Gabrichevskogo», Moskva, Rossija

Korosteleva E.V.

Ryazan State Medical University named after acad. I.P. Pavlov, Department of Eye and ENT Diseases, 9 Vysokovol’tnaya St., Ryazan, Russian Federation, 390024

Vygodin V.A.

National Research Centre for Preventive Medicine, Moscow, Russia

Prediction of activity and severity of endocrine ophthalmopathy by multidimensional linear regression modeling

Authors:

Likhvantseva V.G., Afanasev M.S., Rudenko E.A., Karaulov A.V., Afanas’ev S.S., Korosteleva E.V., Vygodin V.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2018;134(2): 23‑31

Read: 1168 times


To cite this article:

Likhvantseva VG, Afanasev MS, Rudenko EA, Karaulov AV, Afanas’ev SS, Korosteleva EV, Vygodin VA. Prediction of activity and severity of endocrine ophthalmopathy by multidimensional linear regression modeling. Russian Annals of Ophthalmology. 2018;134(2):23‑31. (In Russ.)
https://doi.org/10.17116/oftalma2018134223-30

Recommended articles:
Risk factors asso­ciated with myopic macu­lopathy in acquired myopia. Russian Annals of Ophthalmology. 2024;(5):35-45
Glucocorticoid-resistant forms of endo­crine ophthalmopathy. Russian Annals of Ophthalmology. 2024;(6):125-130
Features of como­rbidity pathology in young people. Russian Journal of Preventive Medi­cine. 2024;(11):63-69
Comparison of models for prediction of spontaneous preterm birth. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):10-19
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
Features of primary and recu­rrent ischemic stroke in men aged 18—50 years. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):65-74

References:

  1. Brovkina AF. Endokrinnaya oftal’mopatiya. M.: Geotar-Med; 2008. (In Russ.)
  2. Badelon I, Mora S. Graves’ ophthalmopathy. Rev Prat. 2005;55(2):183-186.
  3. Wiersinga WM. Pathogenesis of Graves’ Ophthalmopathy — Current Understanding. J Clin Endocrinol Metab. 2001;86(2):501-503.
  4. Dedov II. Federal clinical recommendations regarding diagnostics and treatment by the Graves’ оphthalmopathy. Problemy ehndokrinologii. 2015;61(1):61-74. (In Russ.) https://doi.org/10.14341/probl201561161-74
  5. Burch HB, Wartofsky L. Graves’ ophthalmopathy: current concepts regarding pathogenesis and management. Endocrine Reviews. 1993;14(6):747-793. https://doi.org/10.1210/edrv-14-6-747
  6. Noth D, Gebauer G, Muller B. Graves’ ophthalmopathy: natural history and treatment outcomes. Swiss Med Wkly. 2001;131:603-609.
  7. Likhvantseva VG, Sviridenko NYu, Rudenko EA, Gontyurova OA, Vygodin VA. Special features of the clinical manifestations of Graves’ ophthalmopathy in patient-carriers autoantibodies to tireoperoksidaze. Rossijskij mediko-biologicheskij vestnik im. akad. I.P. Pavlova. 2011;3:69-74. (In Russ.)
  8. Likhvantseva VG, Tabeeva KI. Influence of the form of the treatment of diffuse toxic goiter on the clinical manifestation of the endocrine ophthalmopathy. Medicinskij vestnik MVD. 2010;3:17-22. (In Russ.)
  9. Sviridenko NYu, Likhvantseva VG, Tabeeva KI. Anti-TSH receptor antibodies as predictors of the severity and outcome of endocrine ophthalmopathy in the patients presenting with Graves’ disease. Problemy endokrinologii. 2009;2:19-22. (In Russ.)
  10. Shchegol’kova YuS, Novyh MI, Lazarenko VI, Kadricheva SG, Dogadin SA. Possibilities of forecast and control of the treatment of the patients with endocrine ophthalmopathy. Zhurnal Sibirskoe medicinskoe obozrenie. 2006;42(5):32-34. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.